Andrea Christopher
Corporate Communications and Investor Relations
Replay available
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) Q1 2025 earnings conference call, held 2025-05-12. Replay captured from the company's public earnings webcast.

Corporate Communications and Investor Relations
President and Chief Executive Officer
Chief Financial Officer
Chief Medical Officer
Analyst, TD Cal
Analyst, Jefferies
Analyst, Lyric Partners
Analyst, RBC Capital Markets
Watch the replay and follow the connected company analysis, news, and investor updates for Aurinia Pharmaceuticals Inc.
WEBVTT 00:00:00.301 -- 00:00:04.347 Greetings and welcome to the Aurinia Pharmaceuticals Inc. 00:00:04.347 -- 00:00:10.195 Q1 2025 earnings call. At this time, all participants are in listen-only mode. 00:00:10.195 -- 00:00:14.340 If anyone should require operator assistance, please press star zero on your telephone 00:00:14.340 -- 00:00:15.902 keypad. 00:00:15.902 -- 00:00:19.808 A question and answer session will follow the formal presentation, and you may press 00:00:19.808 -- 00:00:23.513 star one at any time to be placed into question queue. 00:00:23.513 -- 00:00:26.558 As a reminder, this conference is being recorded. 00:00:26.558 -- 00:00:30.945 It's now my pleasure to turn the call over to Andrea Christopher, Corporate Communications 00:00:30.945 -- 00:00:34.992 and Investor Relations. Please go ahead, Andrea. 00:00:34.992 -- 00:00:38.918 Thank you, Operator, and thank you to everyone for joining today's call and webcast. 00:00:38.918 -- 00:00:42.224 Joining me on the call this morning are Peter Greenleaf, Arania's President and Chief 00:00:42.224 -- 00:00:46.471 Executive Officer, Joe Miller, Arania's Chief Financial Officer, and Dr. 00:00:46.471 -- 00:00:48.614 Greg Keenan, Arania's Chief Medical Officer. 00:00:48.614 -- 00:00:53.710 Today, we will review and discuss Arania's first quarter 2025 financial results 00:00:53.710 -- 00:00:57.575 and provide an update on recent corporate progress as communicated in the company's press 00:00:57.575 -- 00:01:02.062 release and quarterly report on Form 10Q issued this morning. 00:01:02.062 -- 00:01:04.906 For more information, please refer to Arrhenius' filings with the U.S. 00:01:04.906 -- 00:01:09.031 Securities and Exchange Commission and Canadian Securities Authorities, which are also 00:01:09.031 -- 00:01:12.89...